"Don't be afraid of buying on a war scare." - Phillip Fisher
A common theme in bioscience investing is that a stock tends to rally vigorously following a strong data release. Thereafter, it can either appreciate further, trade sideways or recede southbound. As such, you need to determine where the stock is heading after a large "pop." If you've been following my work, you'd see that I employ a technique coined high probability event forecasting. As the evolution of my drug approval and clinical outcomes forecasting, high probability event analysis spotted out the Clovis Oncology